CBLN1 and Alzheimer disease: Considering the above mentioned, SL metabolism enzymes alterations observed in different stages of AD lead to an increase in Cer levels (proapoptotic) and a decrease in S1P and C1P (anti-apoptotic) [54,91], which may determine or promote cell fate in the pathophysiology of AD.